首页 | 本学科首页   官方微博 | 高级检索  
     

婴幼儿血管瘤循证治疗现状
引用本文:郑家伟,赵泽亮,陈启铭. 婴幼儿血管瘤循证治疗现状[J]. 中国口腔颌面外科杂志, 2022, 20(1): 7-14. DOI: 10.19438/j.cjoms.2022.01.002
作者姓名:郑家伟  赵泽亮  陈启铭
作者单位:上海交通大学医学院附属第九人民医院 口腔颌面-头颈肿瘤科,上海交通大学口腔医学院,国家口腔医学中心,国家口腔疾病临床医学研究中心,上海市口腔医学重点实验室,上海 200011
基金项目:国家自然科学基金(82071130)。
摘    要:婴幼儿血管瘤是儿童期最常见的良性肿瘤,目前主张早期予以干预,以减少并发症和对心理发育的负面影响。随着β受体阻滞剂的成功应用,治疗方法发生了革命性变化,治疗效果也随之提高。本文结合文献分析,基于循证医学证据,概述了婴幼儿血管瘤各种治疗方法的适应证、优缺点和选择依据,以期为临床应用提供指导。

关 键 词:婴幼儿血管瘤  循证治疗  β受体阻滞剂  
收稿时间:2021-09-20
修稿时间:2021-10-18

Current evidence-based treatment of infantile hemangiomas
ZHENG Jia-wei,ZHAO Ze-liang,CHEN Qi-ming. Current evidence-based treatment of infantile hemangiomas[J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(1): 7-14. DOI: 10.19438/j.cjoms.2022.01.002
Authors:ZHENG Jia-wei  ZHAO Ze-liang  CHEN Qi-ming
Affiliation:Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology. Shanghai 200011, China
Abstract:Infantile hemangioma is the most common benign tumor in childhood.Early intervention is currently advocated so as to minimize complications and negative effects on mental development.With the successful application of variousβ-blockers,the treatment methods have undergone revolutionary changes,and the treatment effect has also been improved.Based on literature review and evidence-based medicine,this article summarized the indications,advantages and disadvantages and selection of various treatment methods for infantile hemangioma,in order to provide guidance for clinical application.
Keywords:Infantile hemangioma  Evidence-based treatment  Beta receptor blockers
本文献已被 维普 等数据库收录!
点击此处可从《中国口腔颌面外科杂志》浏览原始摘要信息
点击此处可从《中国口腔颌面外科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号